Enwei Pharmaceutical Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Public

  • Employees
  • 1,501

Employees

  • Stock Symbol
  • 301331

Stock Symbol

  • Share Price
  • $3.59
  • (As of Friday Closing)

Enwei Pharmaceutical General Information

Description

Enwei Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of proprietary Chinese medicines and chemical medicines. The company mainly procures Chinese medicinal herbs, processed Chinese medicinal herbs, chemical raw materials, excipients, packaging materials, plastics, and other miscellaneous items.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Chuangye Avenue
  • Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region
  • Changdu, Tibet 854000
  • China
+86 028
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • Chuangye Avenue
  • Enwei Building, Economic Development Zone, Aba District, Tibet Autonomous Region
  • Changdu, Tibet 854000
  • China
+86 028

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enwei Pharmaceutical Stock Performance

As of 13-Nov-2026, Enwei Pharmaceutical’s stock price is $3.59. Its current market cap is $370M with 103M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.59 $3.57 $2.79 - $4.83 $370M 103M 2.26M $0.05

Enwei Pharmaceutical Financials Summary

As of 30-Sep-2026, Enwei Pharmaceutical has a trailing 12-month revenue of $120M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 294,633 341,249 285,353 337,953
Revenue 120,307 125,258 113,181 110,983
EBITDA 6,965 15,491 12,778 18,318
Net Income 5,482 7,223 5,226 12,200
Total Assets 214,448 221,628 206,097 188,683
Total Debt 30,240 26,876 27,107 189
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Enwei Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Enwei Pharmaceutical‘s full profile, request access.

Request a free trial

Enwei Pharmaceutical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enwei Pharmaceutical ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Enwei Pharmaceutical’s complete esg history, request access »

Enwei Pharmaceutical FAQs

  • When was Enwei Pharmaceutical founded?

    Enwei Pharmaceutical was founded in 2005.

  • Where is Enwei Pharmaceutical headquartered?

    Enwei Pharmaceutical is headquartered in Changdu, China.

  • What is the size of Enwei Pharmaceutical?

    Enwei Pharmaceutical has 1,501 total employees.

  • What industry is Enwei Pharmaceutical in?

    Enwei Pharmaceutical’s primary industry is Pharmaceuticals.

  • Is Enwei Pharmaceutical a private or public company?

    Enwei Pharmaceutical is a Public company.

  • What is Enwei Pharmaceutical’s stock symbol?

    The ticker symbol for Enwei Pharmaceutical is 301331.

  • What is the current stock price of Enwei Pharmaceutical?

    As of 13-Nov-2026 the stock price of Enwei Pharmaceutical is $3.59.

  • What is the current market cap of Enwei Pharmaceutical?

    The current market capitalization of Enwei Pharmaceutical is $370M.

  • What is Enwei Pharmaceutical’s current revenue?

    The trailing twelve month revenue for Enwei Pharmaceutical is $120M.

  • What is Enwei Pharmaceutical’s annual earnings per share (EPS)?

    Enwei Pharmaceutical’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process